Literature DB >> 11580098

Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells.

R Korhonen1, R Korpela, M Saxelin, M Mäki, H Kankaanranta, E Moilanen.   

Abstract

BACKGROUNDS AND AIMS: Probiotic Lactobacillus rhamnosus GG (LGG) has proved to be beneficial in the treatment of viral- and antibiotic-associated diarrhea but the mechanisms of action remain unknown. Nitric oxide (NO) is involved in the protective mechanisms in the gastrointestinal tract and may contribute to some of the beneficial effects of probiotics. The aim of the present study was to investigate if induction of NO synthesis is involved in the cellular actions of LGG.
METHODS: NO synthesis and its regulation were measured in cultures of J774 murine macrophages and human T84 colon epithelial cells. NO production was measured as its metabolite nitrite accumulated into the culture medium. Inducible nitric oxide synthase (iNOS) protein and iNOS mRNA were detected by Western blot and RT-PCR, respectively.
RESULTS: In J774 macrophages, LGG induced a low level production of NO in the presence of gamma interferon (IFNgamma) and it was inhibited by NOS inhibitors, cycloheximide and by a NF-kappa B inhibitor pyrrolidinedithiocarbamate. Accordingly, LGG and IFNgamma-stimulation increased iNOS mRNA and protein levels. T84 cells produced NO in response to LGG when first primed with a combination of IL-1beta, TNFalpha and IFNgamma. Lipoteichoic acid (LA), an antigenic structure in gram-positive bacteria, also induced NO formation in J774 cells in the presence of IFNgamma suggesting that LA may be the active component in LGG.
CONCLUSIONS: LGG induces NO production in J774 macrophages and in human T84 colon epithelial cells through induction of iNOS by a mechanism involving activation of transcription factor NF-kappaB. Induction of iNOS and low-level synthesis of NO may be involved in the protective actions of LGG in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580098     DOI: 10.1023/a:1010971703271

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  52 in total

1.  Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells.

Authors:  A Paul; K Doherty; R Plevin
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

2.  Nitric oxide and intestinal epithelia: just say NO.

Authors:  S P Colgan
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

3.  Lactobacillus GG and acute diarrhoea in young children in the tropics.

Authors:  A R Pant; S M Graham; S J Allen; S Harikul; A Sabchareon; L Cuevas; C A Hart
Journal:  J Trop Pediatr       Date:  1996-06       Impact factor: 1.165

4.  Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat.

Authors:  B J Whittle; J Lopez-Belmonte; S Moncada
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

5.  Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives.

Authors:  O Kosonen; H Kankaanranta; P Vuorinen; E Moilanen
Journal:  Eur J Pharmacol       Date:  1997-10-15       Impact factor: 4.432

6.  Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor-kappa B-dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin.

Authors:  M Lähde; R Korhonen; E Moilanen
Journal:  Aliment Pharmacol Ther       Date:  2000-07       Impact factor: 8.171

7.  Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability.

Authors:  D Payne; P Kubes
Journal:  Am J Physiol       Date:  1993-07

8.  Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea.

Authors:  M Kaila; E Isolauri; M Saxelin; H Arvilommi; T Vesikari
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

9.  Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea.

Authors:  A Guarino; R B Canani; M I Spagnuolo; F Albano; L Di Benedetto
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-11       Impact factor: 2.839

10.  Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method.

Authors:  H Wong; W D Anderson; T Cheng; K T Riabowol
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

View more
  21 in total

Review 1.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  Current Perspectives on Antihypertensive Probiotics.

Authors:  Eric Banan-Mwine Daliri; Byong H Lee; Deog H Oh
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

3.  Lactobacillus delbrueckii subsp. lactis (strain CIDCA 133) stimulates murine macrophages infected with Citrobacter rodentium.

Authors:  Ayelén A Hugo; Ivanna S Rolny; David Romanin; Pablo F Pérez
Journal:  World J Microbiol Biotechnol       Date:  2017-02-07       Impact factor: 3.312

4.  Probiotics and prebiotics for the prevention of necrotizing enterocolitis.

Authors:  Michael R Stenger; Kristina M Reber; Peter J Giannone; Craig A Nankervis
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

5.  Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid.

Authors:  Riku Korhonen; Riitta Korpela; Eeva Moilanen
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

6.  Effects of strains of Lactococcus lactis on the production of nitric oxide and cytokines in murine macrophages.

Authors:  Chise Suzuki; Ayako Aoki-Yoshida; Hiromi Kimoto-Nira; Miho Kobayashi; Keisuke Sasaki; Koko Mizumachi
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

7.  Effects of probiotic on intestinal mucosa of patients with ulcerative colitis.

Authors:  Hai-Hong Cui; Cun-Long Chen; Ji-De Wang; Yu-Jie Yang; Yong Cun; Jin-Bao Wu; Yu-Hu Liu; Han-Lei Dan; Yan-Ting Jian; Xue-Qing Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

Review 8.  A Review of the Effects and Production of Spore-Forming Probiotics for Poultry.

Authors:  Igor V Popov; Ammar Algburi; Evgeniya V Prazdnova; Maria S Mazanko; Vladimir Elisashvili; Anzhelica B Bren; Vladimir A Chistyakov; Elizaveta V Tkacheva; Vladimir I Trukhachev; Irina M Donnik; Yuri A Ivanov; Dmitry Rudoy; Alexey M Ermakov; Richard M Weeks; Michael L Chikindas
Journal:  Animals (Basel)       Date:  2021-06-29       Impact factor: 2.752

9.  Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.

Authors:  Altug Senol; Mehmet Isler; Recep Sutcu; Mete Akin; Ebru Cakir; Betul M Ceyhan; M Cem Kockar
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

10.  Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria.

Authors:  J Marcinkiewicz; M Ciszek; M Bobek; M Strus; P B Heczko; M Kurnyta; R Biedroń; A Chmielarczyk
Journal:  Int J Exp Pathol       Date:  2007-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.